Clincosm LogoSign in Get a demo

Influenza, Human

Showing 26 - 50 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)

Recruiting
  • Influenza, Human
  • COVID-19
  • bivalent BNT162b2 (original/Omi BA.4/BA.5)
  • +2 more
  • Athens, Alabama
  • +18 more
Dec 22, 2022

Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))

Completed
  • Influenza, Human
  • Treatment Group Live Attenuated Flu Vaccine (LAIV)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 16, 2022

Influenza, Human Trial in Philadelphia (Seasonal influenza vaccine)

Recruiting
  • Influenza, Human
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 17, 2022

Does Repeat Influenza Vaccination Constrain Influenza Immune

Recruiting
  • Influenza, Human
  • SARS-CoV-2 Infection
  • Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
  • SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
  • New Lambton Heights, New South Wales, Australia
  • +5 more
Nov 7, 2022

Influenza, Human Trial in United States (NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo)

Terminated
Has Results
  • Influenza, Human
  • NanoFlu (Quad-NIV)
  • +5 more
  • Hollywood, Florida
  • +13 more
Nov 3, 2022

Influenza, Human Trial (Clarithromycin 250 MG, Placebos)

Suspended
  • Influenza, Human
  • Clarithromycin 250 MG
  • Placebos
  • Hong Kong, Hong Kong
    School of Public Health, The University of Hong Kong
Nov 1, 2022

Influenza, Human Trial in United States (Quadrivalent influenza modRNA vaccine, Quadrivalent influenza vaccine)

Recruiting
  • Influenza, Human
  • Quadrivalent influenza modRNA vaccine
  • Quadrivalent influenza vaccine
  • Athens, Alabama
  • +92 more
Sep 15, 2022

Influenza, Human Trial (Fluzone Quadrivalent, Flublok Quadrivalent)

Not yet recruiting
  • Influenza, Human
  • Fluzone Quadrivalent
  • Flublok Quadrivalent
  • (no location specified)
Aug 22, 2022

Influenza, Human Trial in Sacramento (Procalcitonin, Pharmacist-Led Education)

Completed
  • Influenza, Human
  • Procalcitonin
  • Pharmacist-Led Education
  • Sacramento, California
    University of California, Davis Medical Center
Aug 16, 2022

Influenza, Human Trial in United States (mIRV, bIRV AB, qIRV)

Recruiting
  • Influenza, Human
  • mIRV
  • +5 more
  • Athens, Alabama
  • +97 more
Aug 16, 2022

Influenza, Human Trial in United States (Experimental: IIV-A Investigational IIV-A will be administered as a single dose

Not yet recruiting
  • Influenza, Human
  • Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1
  • +3 more
  • Tempe, Arizona
  • +44 more
Aug 16, 2022

Influenza, Human, Respiratory Syncytial Virus Infections Trial in United States (Swab)

Recruiting
  • Influenza, Human
  • Respiratory Syncytial Virus Infections
  • Swab
  • Birmingham, Alabama
  • +19 more
Aug 16, 2022

Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

Active, not recruiting
  • COVID-19
  • +2 more
  • Blood sample
  • London, United Kingdom
  • +1 more
Aug 8, 2022

Influenza, Human Trial in Feicheng City (Quadrivalent Influenza Virus Split Vaccine)

Recruiting
  • Influenza, Human
  • Quadrivalent Influenza Virus Split Vaccine
  • Feicheng City, Shandong, China
    Tingting and Yu
Aug 3, 2022

Influenza, Human, Pneumonia, Pneumococcal Trial in Quanzhou, Qingzhen, Qidong (IIV4 and PPV23, IIV4, PPV23)

Completed
  • Influenza, Human
  • Pneumonia, Pneumococcal
  • IIV4 and PPV23
  • +2 more
  • Quanzhou, Fujian, China
  • +3 more
Aug 1, 2022

Influenza, Human, Influenza in Birds, Respiratory Tract Infections Trial in United States (aH5N6c on Day 1, aH5N6c on Day 22,

Recruiting
  • Influenza, Human
  • +7 more
  • aH5N6c on Day 1
  • +2 more
  • Huntsville, Alabama
  • +17 more
Jul 26, 2022

Influenza, Human Trial in Estonia, Germany, United States (aQIV, Comparator QIV)

Active, not recruiting
  • Influenza, Human
  • aQIV
  • Comparator QIV
  • Mobile, Alabama
  • +28 more
Jul 26, 2022

Influenza, Human, Vaccination; Infection, Vaccines Trial in Saint Petersburg (Flu-M, Inactivated split influenza vaccine 0.5 mL,

Completed
  • Influenza, Human
  • +2 more
  • Flu-M, Inactivated split influenza vaccine 0.5 mL
  • +3 more
  • Saint Petersburg, Russian Federation
  • +1 more
Jul 19, 2022

Influenza, Human Trial in Estonia, Philippines (H5N1 antigen combined with MF59 adjuvant)

Completed
  • Influenza, Human
  • H5N1 antigen combined with MF59 adjuvant
  • Tallinn, Harjumaa, Estonia
  • +6 more
Jul 21, 2022

Influenza, Human, Transplantation Infection Trial in Falls Church (influenza trivalent inactive vaccine, influenza trivalent

Completed
Has Results
  • Influenza, Human
  • Transplantation Infection
  • influenza trivalent inactive vaccine
  • influenza trivalent inactive vaccine high dose
  • Falls Church, Virginia
    Inova Fairfax Hospital
Jul 20, 2022

Influenza, Human, Vaccination; Infection, Vaccines Trial in Russian Federation (Flu-M, Inactivated split influenza vaccine,

Completed
  • Influenza, Human
  • +2 more
  • Flu-M, Inactivated split influenza vaccine
  • Ultrix®, Inactivated Split Influenza Vaccine
  • Barnaul, Altai Territory, Russian Federation
  • +4 more
Jul 11, 2022

Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

Terminated
  • Respiratory Syncytial Virus Infections
  • Influenza, Human
  • RSV A Memphis 37
  • Influenza A/California/04/2009
  • London, United Kingdom
    National Heart and Lung Institute, Imperial College London
Jun 23, 2022

Influenza, Human Trial in Morayfield (CODA-VAX H1N1, Flucelvax Quad, Saline)

Active, not recruiting
  • Influenza, Human
  • CODA-VAX H1N1
  • +2 more
  • Morayfield, Queensland, Australia
    Amy Goh, Study Coordinator
Jun 24, 2022

Influenza, Influenza, Human, Influenza -Like Illness Trial in Norfolk (Oseltamivir, Baloxavir)

Recruiting
  • Influenza
  • +2 more
  • Norfolk, Virginia
    Insight Therapeutics, LLC
Jun 14, 2022

Influenza, Human, Arthralgia Trial in Worldwide (Zanamivir)

Not yet recruiting
  • Influenza, Human
  • Arthralgia
  • Nijmegen, Netherlands
  • +4 more
Jun 2, 2022